Paloma Partners’s Calidi Biotherapeutics CLDI Stock Holding History

Paloma Partners’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-505	Closed	-$622K	–	771
2023 Q1	$622K	Hold	505	–	–	0.02%	460
2022 Q4	$616K	Hold	505	–	–	0.03%	469
2022 Q3	$597K	Hold	505	–	–	0.03%	435
2022 Q2	$602K	Hold	505	–	–	0.02%	565
2022 Q1	$599K	Hold	505	–	–	0.02%	654
2021 Q4	$594K	Buy	+505	New	+$595K	0.01%	1016

Other funds holding CLDI

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return